Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000880827 | SCV001023949 | benign | EGFR-related lung cancer | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002258025 | SCV002537701 | benign | Hereditary cancer-predisposing syndrome | 2020-10-09 | criteria provided, single submitter | curation | |
Breakthrough Genomics, |
RCV004712927 | SCV005273270 | benign | not provided | criteria provided, single submitter | not provided | ||
Ambry Genetics | RCV002258025 | SCV005579577 | likely benign | Hereditary cancer-predisposing syndrome | 2024-08-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |